In addition to BCR-ABL1, by inhibiting VEGFR, FGFR, PDGFR, KIT, and FLT3, it can slow down cancer growth, reduce blood supply to the tumor and help kill cancer cells. The gene discussed is PDGFRB; the disease is neoplasm.